All terms in HP
Label | Id | Description |
---|---|---|
positive regulation of plasma membrane bounded cell projection assembly | GO_0120034 | [Any process that activates or increases the frequency, rate or extent of plasma membrane bounded cell projection assembly.] |
negative regulation of response to extracellular stimulus | GO_0032105 | [Any process that stops, prevents, or reduces the frequency, rate or extent of a response to an extracellular stimulus.] |
negative regulation of bleb assembly | GO_1904171 | [Any process that stops, prevents or reduces the frequency, rate or extent of bleb assembly.] |
negative regulation of plasma membrane bounded cell projection assembly | GO_0120033 | [Any process that stops, prevents or reduces the frequency, rate or extent of plasma membrane bounded cell projection assembly.] |
negative regulation of response to nutrient levels | GO_0032108 | [Any process that stops, prevents, or reduces the frequency, rate or extent of a response to nutrient levels.] |
regulation of response to nutrient levels | GO_0032107 | [Any process that modulates the frequency, rate or extent of a response to nutrient levels.] |
response to nutrient levels | GO_0031667 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of nutrients.] |
Abnormality of the maxilla | HP_0000326 | [An abnormality of the Maxilla (upper jaw bone).] |
Abnormal jaw morphology | HP_0030791 | [A structural anomaly of the jaw, the bony structure of the mouth that consists of the mandible and the maxilla.] |
positive regulation of response to nutrient levels | GO_0032109 | [Any process that activates or increases the frequency, rate or extent of a response to nutrient levels.] |
Hypoplasia of the maxilla | HP_0000327 | [Abnormally small dimension of the Maxilla. Usually creating a malocclusion or malalignment between the upper and lower teeth or resulting in a deficient amount of projection of the base of the nose and lower midface region.] |
Aplasia/Hypoplasia of the maxilla | HP_0009117 | [Absence or underdevelopment of the maxilla.] |
ulcer | MPATH_579 | [Loss of epithelium and the basement membrane (full thickness). Cf Erosion.] |
cell and tissue damage | MPATH_1 | [The sum of morphological and functional disturbances induced by cell and tissue damage, either from intrinsic gene dysfunction or as a result of external factors.] |
Facial hemangioma | HP_0000329 | [Hemangioma, a benign tumor of the vascular endothelial cells, occurring in the face.] |
Elevated hepatic transaminase | HP_0002910 | [Elevations of the levels of SGOT and SGPT in the serum. SGOT (serum glutamic oxaloacetic transaminase) and SGPT (serum glutamic pyruvic transaminase) are transaminases primarily found in the liver and heart and are released into the bloodstream as the result of liver or heart damage. SGOT and SGPT are used clinically mainly as markers of liver damage.] |
chondroitin D-glucuronate anion | CHEBI_57652 | [Anionic form of chondroitin D-glucuronate arising from deprotonation of the carboxylic acid groups of the repeating units; major species at pH 7.3.] |
polyanionic polymer | CHEBI_61469 | [A polymer, composed of polyanion macromolecules.] |
chondroitin D-glucuronate | CHEBI_16137 | [A mucopolysaccharide composed of repeating beta-D-glucopyranuronosyl-(1->3)-beta-D-N-acetylgalactosaminyl units.] |
growth involved in symbiotic interaction | GO_0044110 | [The increase in size or mass of an organism occurring when the organism is in a symbiotic interaction.] |